Mandate

Vinge advises KKR on its significant investment in Söderberg & Partners

February 08, 2019 M&A

Vinge has advised the global investment firm KKR in connection with KKR entering into an agreement with Söderberg & Partners, TA Associates and certain other selling shareholders to acquire a substantial minority shareholding in Söderberg & Partners.

The transaction is subject to customary conditions precedent including regulatory approvals, and is expected to be completed during the second quarter of 2019. 

Söderberg & Partners is a leading non-bank provider of wealth management and corporate pension and insurance services in the Nordic region and the Netherlands. KKR will continue to support and assist Söderberg & Partners on its strategy of rolling out its successful platform across the Nordic region and internationally, developing its product portfolio and services proposition, and enhancing its capabilities across investment management and research.

Vinge’s team consisted of, among others, Christina Kokko, Johan Larsson, Samra Baytar, Desirée Sjöblom, Elsie Nassar and Hanna Risberg (Corporate and M&A), Emma Stuart-Beck, Caroline Krassén, Malin Haag, Henrik Schön, Mikaela Lang and Julia Hirschberg (Regulatory and Financial Services) Viveka Classon, Paulina Malmberg (Insurance), Isabell Nielsen (Commercial Agreements), Lisa Ullman (Employment), Nicklas Thorgerzon (IT), Vilhelm Rondahl and Josefine Lanker (Banking and Financing), Agnes Perbo and Karolina Cohrs (Real Estate/Lease Agreements), Sofia Bergenstråhle (IP) and Viktoria Owetz (VDR assistant).

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025